Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (1.572.156 €): Sofortige, allgegenwärtige und erschwingliche Bilddiagnose, die die Leistungsfähigkeit von KI, Smartphones und 3D-Druck kombiniert, um die universelle Diagnose bis 2030 zu … Hor 01.11.2019 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Auf einen Blick
Text
Sofortige, allgegenwärtige und erschwingliche Bilddiagnose, die die Leistungsfähigkeit von KI, Smartphones und 3D-Druck kombiniert, um die universelle Diagnose bis 2030 zu erreichen
Early detection of both infectious diseases and chronic diseases plays a crucial role in all treatment and prevention strategies. Population ageing and healthcare budget pressures do not contribute to ease the pain under this scenario. Optic microscopy is still the gold standard for diagnosing several tens of pathologies. However, physicians have been using almost the same technology to detect diseases for the past 150 years, by manually reviewing samples under a microscope. This requires the time of an expert analyst at the right place and at the right moment as the sample is been taken, something not always available and affordable. SpotLab’s solution sits in the convergence of the physical and the digital world to reduce time, costs and distances of microscopy diagnosis. SpotLab is a diagnosis-as-a-service company based on three technological pillars: (1) a smartphone transformed into a portable, intelligent and low-cost medical device, manufactured with 3D printing and consumer electronics, (2) a flexible and easy to use telemedicine platform that can be tailored to multiple diagnosis protocols that is connected to the knowledge of worldwide physicians; and (3) a factory of AI models that prioritizes cases and assists diagnosis for multiple pathologies. After 5 years of research at the Universidad Politécnica de Madrid, SpotLab S.L. was founded in 2017. We are a multidisciplinary orchestra with a diverse team of 14 people, internationally awarded and recognized by our capacity of creating responsible innovation and products in the digital health space. SpotLab´s seed round allowed us to bring our product to TRL6. We need EU funding to complement our new investment round and industrialize our product (TRL6 to TLR9), obtain the relevant regulatory certifications (CE Mark); and validate its market disruption in dif SpotLab´s team motivation is to create a positive impact in the world. We prefer to provide 1 million diagnoses at €1 than 1 diagnosis at €1 million
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Spotlab SL | 1.572.156 € |
Quelle: https://cordis.europa.eu/project/id/881062
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der letzte verfügbare Stand wird auf folgender Seite wiedergegeben: Spotlab SL, Madrid, Spanien.